news
Jan 28 2015
AnaMar Announces Strategic Realignment and 2015 Corporate Priorities
Jan 28 2015
Gynecologic Oncology Group (GOG) Phase 2 Study of Advaxis's Lm-LLO Immunotherapy, ADXS-HPV, for the Treatment of Persistent or Recurrent Cervical Cancer Achieves Safety and Efficacy Criteria
Jan 28 2015
Galena Biopharma to Present at the 17th Annual BIO CEO & Investor Conference
 |
|
events
Jan 17-21 2015
Society of Critical Care Medicine Annual Congress
Jan 18-21 2015
Noble Financial Capital Markets 11th Annual Investor Conference
Jan 28-30 2015
Drug Delivery Partnerships
Feb 9-10 2015
BIO CEO & Investor Conference
Feb 23-24 2015
3rd Annual Sachs Cancer Bio Partnering & Investment Forum
|
|
spotlight
|
